The overall purpose of this study is to objectively describe and test the consistency and reproducibility of instrument-assisted soft tissue manipulation (IASTM).The specific aims of this current study are to: 1. Analyze IASTM stroke patterns using objective metrics; 2. Test the consistency of force application, with and without visual monitoring of objective metrics, and; 3. Determine the reliability of dynamic pressure pain threshold assessment. The ultimate goal of this continuing line of research is to improve soft tissue manual therapy practice in research, education, and clinic for use as a non-invasive modality in soft tissue assessment and treatment. Results from this protocol will inform future clinical trials, including studies exploring the effects of different IASTM dose-loads in various musculoskeletal pain conditions.
This is a single-site study consisting of three study phases. Phase I will observe and analyze clinician's application of instrument-assisted soft tissue manipulation (IASTM) as a means to identify signature profiles for the stroke rate, angle, and direction that are characteristic of basic (e.g., linear, curved) stroke patterns. Phase II will assess the consistency of IASTM force application. Phase III will assess the reliability of dynamic pressure pain threshold assessment. Clinician participants (Phase I) will attend one study visit consisting of basic linear and curved IASTM stroke pattern applications and complete a questionnaire. Total study duration for clinician participants will be 90 minutes. Non-clinician subjects will attend two study visits (Phase II) or one study visit (Phase III). Visits will consist of completion of questionnaires, application of IASTM strokes by a clinician using the QSTM device, and stretching.
Study Type
OBSERVATIONAL
Enrollment
106
Quantifiable soft tissue manipulation (QSTM) is a force sensing device system that can be used by a clinician to apply a massaging force while the system monitors objective metrics, i.e., the amount, rate, and angle of force applied.
Indiana University
Indianapolis, Indiana, United States
Phase I Stroke Pattern Characteristic Descriptions
The objectives metrics from quantifiable soft tissue manipulation device system will be analyzed for common or characteristic applications between clinicians.
Time frame: Analysis results within 6 months.
Phase II Reliability of IASTM Force Application
The agreement in soft tissue manipulation force application, between and within clinicians, will be determined within a single session and between session (within 7 days apart).
Time frame: Measured within 2 hours for same day reliability and at 7 days for between day reliability. Results reported by end of study at one year
Phase III Reliability of Dynamic Pressure Pain Threshold Assessment
The agreement between and within clinicians in pressure pain threshold assessment over a body area will be determined within a single session.
Time frame: Measured within 2 hours on same day of testing. Results reported by end of study at one year.
(Phase III Only) Heart Rate
Radial pulse will be palpated to determine heart rate (in beats per minute, BPM).
Time frame: Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.
(Phase III Only) Blood Pressure
Will determine systolic and diastolic blood pressure (in mmHg) using a stethoscope and sphygmomanometer.
Time frame: Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.
(Phase III Only) Range of Motion
Will measure the amount (range) of trunk movement (in degrees) using a modified protractor.
Time frame: Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.
(Phase III Only) Hamstring Length Flexibility Test.
Will measure the amount (range) of passive knee extension movement available (in degrees) with the hip stabilized at 90 degrees using a modified protractor.
Time frame: Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.
(Phase III Only) Trunk Forward Bend Flexibility Test.
A tape measurer/ruler will be used to determine the extensibility (e.g. limberness) of the posterior (back) trunk soft tissues during seated trunk forward bend (reaching) muscle length test (change from start to end of test measured in centimeters).
Time frame: Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.
(Phase III Only) Strength
A handheld dynamometer will be used to test the strength (Newtons of force) of the subject's back and thigh.
Time frame: Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.
(Phase III Only) Static Pressure Pain Threshold
This test will determine a subject's pressure pain sensitivity in a single spot using a non-invasive device, i.e. static algometer.
Time frame: Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.
(Phase III Only) Skin Surface Temperature
Changes in skin surface temperature will be determined using an infrared thermometer of the skin are where IASTM is applied on the back and thigh.
Time frame: Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.
(Phase III Only) 10-Meter Walk Test (10-MWT)
Maximal walking speed (MWS) (in meters/sec) will be determined using the 10-meter walk test as a functional performance measure.
Time frame: Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.
(Phase III Only) Vertical Jump Test
The vertical jumping height (in centimeters) (only in subjects 18-30 y.o.) will be determined as a functional performance measure
Time frame: Measured before and within 2 hours after IASTM force application. Results reported by end of study at one year.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.